Ultragenyx Pharmaceutical (RARE) Selling, General & Administrative (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) Selling, General & Administrative (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.70 Bn | 2.28 Bn | 106.00 Mn | 88.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.00 Mn |
| Dec 31, 2025 | 87.94 Mn |
| Sep 30, 2025 | 86.62 Mn |
| Jun 30, 2025 | 86.65 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 81.89 Mn |
| Sep 30, 2024 | 80.35 Mn |
| Jun 30, 2024 | 80.60 Mn |
| Mar 31, 2024 | 78.16 Mn |
| Dec 31, 2023 | 77.03 Mn |
| Sep 30, 2023 | 74.92 Mn |
| Jun 30, 2023 | 81.40 Mn |
| Mar 31, 2023 | 76.65 Mn |
| Dec 31, 2022 | 72.85 Mn |
| Sep 30, 2022 | 69.84 Mn |
| Jun 30, 2022 | 68.14 Mn |
| Mar 31, 2022 | 67.31 Mn |
| Dec 31, 2021 | 59.43 Mn |
| Sep 30, 2021 | 53.88 Mn |
| Jun 30, 2021 | 53.41 Mn |